Rhode Island 2023 Regular Session

Rhode Island Senate Bill S1009

Introduced
5/15/23  
Refer
5/15/23  
Report Pass
6/13/23  
Engrossed
6/14/23  
Enrolled
6/15/23  

Caption

The Rhode Island Cannabis Act

Impact

The enactment of S1009 is expected to significantly affect how cannabis is regulated in Rhode Island. It allows for hybrid cannabis retailers to operate with clear guidelines for compliance regarding sales of both medical and adult use cannabis. Importantly, the bill mandates that these retailers maintain separate inventory systems for adult use and medical sales, ensuring that the needs of medical patients are not overshadowed by adult use demands. This balance is aimed at sustaining the integrity of the medical cannabis program while expanding access to adult users. Moreover, the inclusion of advertising regulations will help maintain responsible marketing practices as the cannabis market grows.

Summary

S1009, also known as the Rhode Island Cannabis Act, modifies existing regulations governing the production, regulation, sale, and use of cannabis within the state. The bill facilitates a transitional period during which the office of cannabis regulation will oversee specific regulatory functions while the commission’s formal rules and regulations are being finalized. This transitional authority is essential for allowing hybrid cannabis retailers to adapt to the evolving landscape of cannabis sales encompassing both adult use and medical markets. In particular, the act outlines the procedures for licensing hybrid retailers and cultivators, facilitating a smoother integration of both markets under a unified regulatory framework.

Contention

During discussions surrounding S1009, stakeholders expressed varying opinions on its implications. Supporters highlighted the necessity of establishing a clear regulatory framework that fosters business growth and ensures consumer safety. Conversely, opponents raised concerns about whether the transitional authority would adequately protect public health and safety, particularly in regards to the potential for inadequate separation between medical and adult use cannabis. This contention underscores the ongoing dialogue about the best approach to regulating a rapidly evolving cannabis industry, balancing economic opportunity against public health considerations.

Companion Bills

No companion bills found.

Similar Bills

OK SB813

Medical marijuana; authorizing the Oklahoma Medical Marijuana Authority to operate a quality assurance laboratory. Emergency.

OK SB813

Medical marijuana; authorizing the Oklahoma Medical Marijuana Authority to operate a quality assurance laboratory. Emergency.

OK HB4056

Medical marijuana; Laboratory recommendations, standards and operating procedures; Oklahoma Medical Marijuana Authority; rules; emergency.

OK SB264

Medical marijuana; modifying application method for certain entities; modifying various action duties and functions of the Oklahoma Medical Marijuana Authority. Effective date.

OK SB264

Medical marijuana; modifying application method for certain entities; modifying various action duties and functions of the Oklahoma Medical Marijuana Authority. Effective date.

CT HB05458

An Act Concerning The Regulation Of The Retail Sale Of Marijuana.

OK HB4055

Medical marijuana; requiring licensed commercial growers to inform retail suppliers or electric cooperatives their license status; report monthly commodity usage; Oklahoma Medical Marijuana Authority; monitoring; effective date.

LA SB143

Enacts Alison Neustrom Act and provides relative to prescribed marijuana for therapeutic uses and the development of rules and regulations by the Louisiana Board of Pharmacy and the Louisiana State Board of Medical Examiners. (gov sig)